LEASE BY AND BETWEEN SNH MEDICAL OFFICE PROPERTIES TRUST, a Maryland real estate investment trust, as Landlord, AND CYTEK BIOSCIENCES, INC., a Delaware corporation, as Tenant 47215/47211 Lakeview Boulevard, Fremont, California 94538Lease Agreement • July 2nd, 2021 • Cytek BioSciences, Inc. • Laboratory analytical instruments • California
Contract Type FiledJuly 2nd, 2021 Company Industry Jurisdiction
SETTLEMENT, LICENSE, AND EQUITY ISSUANCE AGREEMENTSettlement, License, and Equity Issuance Agreement • July 2nd, 2021 • Cytek BioSciences, Inc. • Laboratory analytical instruments • Delaware
Contract Type FiledJuly 2nd, 2021 Company Industry JurisdictionThis SETTLEMENT, LICENSE, AND EQUITY ISSUANCE AGREEMENT (this “Agreement”) is made and entered into as of October 5, 2020 (the “Effective Date”), by and between Becton, Dickinson and Company, a New Jersey corporation having a place of business at 1 Becton Drive, Franklin Lakes, New Jersey 07417, (“BD”), and Cytek Biosciences Inc., a Delaware corporation having a place of business at 46107 Landing Parkway, Fremont, California 94538 (“Cytek”). BD and Cytek are each referred to herein as a “Party,” and collectively as the “Parties.”
SUPPLY & LICENSE AGREEMENTSupply & License Agreement • July 2nd, 2021 • Cytek BioSciences, Inc. • Laboratory analytical instruments • California
Contract Type FiledJuly 2nd, 2021 Company Industry JurisdictionThis Supply and License Agreement (this “Agreement”), made as of September 1, 2020 (“Effective Date”), is by and between BIOTIUM, INC. (“BIOTIUM”), a California corporation with a place of business at 46117 Landing Parkway, Fremont, CA 94538, and CYTEK BIOSCIENCES, INC., a Delaware corporation with place of business at 46107 Landing Parkway, Fremont, CA 94538 (along with its Affiliates, “LICENSEE”).
CYTEK BIOSCIENCES, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • July 2nd, 2021 • Cytek BioSciences, Inc. • Laboratory analytical instruments • Delaware
Contract Type FiledJuly 2nd, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 23rd day of October, 2020, by and among Cytek BioSciences, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder”, and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 8.9 hereof.